| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |